Literature DB >> 24092923

SH2B3: a new leukemia predisposition gene.

Cheryl L Willman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24092923      PMCID： PMC3790499          DOI： 10.1182/blood-2013-08-519843

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.

Authors:  Fanny Baran-Marszak; Hajer Magdoud; Christophe Desterke; Anabell Alvarado; Claudine Roger; Stéphanie Harel; Elizabeth Mazoyer; Bruno Cassinat; Sylvie Chevret; Carole Tonetti; Stéphane Giraudier; Pierre Fenaux; Florence Cymbalista; Nadine Varin-Blank; Marie-Caroline Le Bousse-Kerdilès; Jean-Jacques Kiladjian; Laura Velazquez
Journal:  Blood       Date:  2010-09-24       Impact factor: 22.113

2.  Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation.

Authors:  Y Li; X He; J Schembri-King; S Jakes; J Hayashi
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

3.  Genetic loss of SH2B3 in acute lymphoblastic leukemia.

Authors:  Arianne Perez-Garcia; Alberto Ambesi-Impiombato; Michael Hadler; Isaura Rigo; Charles A LeDuc; Kara Kelly; Chaim Jalas; Elisabeth Paietta; Janis Racevskis; Jacob M Rowe; Martin S Tallman; Maddalena Paganin; Giuseppe Basso; Wei Tong; Wendy K Chung; Adolfo A Ferrando
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

4.  Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

Authors:  Kathryn G Roberts; Ryan D Morin; Jinghui Zhang; Martin Hirst; Yongjun Zhao; Xiaoping Su; Shann-Ching Chen; Debbie Payne-Turner; Michelle L Churchman; Richard C Harvey; Xiang Chen; Corynn Kasap; Chunhua Yan; Jared Becksfort; Richard P Finney; David T Teachey; Shannon L Maude; Kane Tse; Richard Moore; Steven Jones; Karen Mungall; Inanc Birol; Michael N Edmonson; Ying Hu; Kenneth E Buetow; I-Ming Chen; William L Carroll; Lei Wei; Jing Ma; Maria Kleppe; Ross L Levine; Guillermo Garcia-Manero; Eric Larsen; Neil P Shah; Meenakshi Devidas; Gregory Reaman; Malcolm Smith; Steven W Paugh; William E Evans; Stephan A Grupp; Sima Jeha; Ching-Hon Pui; Daniela S Gerhard; James R Downing; Cheryl L Willman; Mignon Loh; Stephen P Hunger; Marco A Marra; Charles G Mullighan
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

5.  Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2.

Authors:  Alexey Bersenev; Chao Wu; Joanna Balcerek; Wei Tong
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

6.  A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.

Authors:  Monique L Den Boer; Marjon van Slegtenhorst; Renée X De Menezes; Meyling H Cheok; Jessica G C A M Buijs-Gladdines; Susan T C J M Peters; Laura J C M Van Zutven; H Berna Beverloo; Peter J Van der Spek; Gaby Escherich; Martin A Horstmann; Gritta E Janka-Schaub; Willem A Kamps; William E Evans; Rob Pieters
Journal:  Lancet Oncol       Date:  2009-01-08       Impact factor: 41.316

7.  JAK mutations in high-risk childhood acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Jinghui Zhang; Richard C Harvey; J Racquel Collins-Underwood; Brenda A Schulman; Letha A Phillips; Sarah K Tasian; Mignon L Loh; Xiaoping Su; Wei Liu; Meenakshi Devidas; Susan R Atlas; I-Ming Chen; Robert J Clifford; Daniela S Gerhard; William L Carroll; Gregory H Reaman; Malcolm Smith; James R Downing; Stephen P Hunger; Cheryl L Willman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-22       Impact factor: 11.205

8.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Xiaoping Su; Jinghui Zhang; Ina Radtke; Letha A A Phillips; Christopher B Miller; Jing Ma; Wei Liu; Cheng Cheng; Brenda A Schulman; Richard C Harvey; I-Ming Chen; Robert J Clifford; William L Carroll; Gregory Reaman; W Paul Bowman; Meenakshi Devidas; Daniela S Gerhard; Wenjian Yang; Mary V Relling; Sheila A Shurtleff; Dario Campana; Michael J Borowitz; Ching-Hon Pui; Malcolm Smith; Stephen P Hunger; Cheryl L Willman; James R Downing
Journal:  N Engl J Med       Date:  2009-01-07       Impact factor: 91.245

9.  Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3.

Authors:  De-Chen Lin; Tong Yin; Maya Koren-Michowitz; Ling-Wen Ding; Saskia Gueller; Sigal Gery; Takayuki Tabayashi; Ulla Bergholz; Julhash U Kazi; Lars Rönnstrand; Carol Stocking; H Phillip Koeffler
Journal:  Blood       Date:  2012-08-31       Impact factor: 22.113

10.  Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice.

Authors:  Laura Velazquez; Alec M Cheng; Heather E Fleming; Caren Furlonger; Shirly Vesely; Alan Bernstein; Christopher J Paige; Tony Pawson
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307
  10 in total
  7 in total

1.  TGF-β1/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2/STAT3 and SHP2/Grb2 signaling pathways.

Authors:  Li-Na Wang; Zi-Teng Zhang; Li Wang; Hai-Xiang Wei; Tao Zhang; Li-Ming Zhang; Hang Lin; Heng Zhang; Shao-Qiang Wang
Journal:  Cell Death Dis       Date:  2022-05-19       Impact factor: 9.685

2.  Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction.

Authors:  Zheng Ge; Yan Gu; Lichan Xiao; Qi Han; Jianyong Li; Baoan Chen; James Yu; Yuka Imamura Kawasawa; Kimberly J Payne; Sinisa Dovat; Chunhua Song
Journal:  Oncotarget       Date:  2016-07-19

3.  Characterization of hsa_circ_0004277 as a New Biomarker for Acute Myeloid Leukemia via Circular RNA Profile and Bioinformatics Analysis.

Authors:  Wei Li; Chaoqin Zhong; Jun Jiao; Peng Li; Baoxia Cui; Chunyan Ji; Daoxin Ma
Journal:  Int J Mol Sci       Date:  2017-03-09       Impact factor: 5.923

4.  CTLA-4 blockade and interferon-α induce proinflammatory transcriptional changes in the tumor immune landscape that correlate with pathologic response in melanoma.

Authors:  Arjun Khunger; Erin Piazza; Sarah Warren; Thomas H Smith; Xing Ren; Andrew White; Nathan Elliott; Alessandra Cesano; Joseph M Beechem; John M Kirkwood; Ahmad A Tarhini
Journal:  PLoS One       Date:  2021-01-11       Impact factor: 3.240

5.  Analysis of Tryptophan and Its Main Metabolite Kynurenine and the Risk of Multiple Cancers Based on the Bidirectional Mendelian Randomization Analysis.

Authors:  Ran Li; Xuanyang Wang; Yuntao Zhang; Xiaoqing Xu; Lulu Wang; Chunbo Wei; Lin Liu; Ziqi Wang; Ying Li
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

6.  Identifying Significant Features in Cancer Methylation Data Using Gene Pathway Segmentation.

Authors:  Zena M Hira; Duncan F Gillies
Journal:  Cancer Inform       Date:  2016-09-20

Review 7.  Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.

Authors:  Pavan Kumar Dhanyamraju; Soumya Iyer; Gayle Smink; Yevgeniya Bamme; Preeti Bhadauria; Jonathon L Payne; Elanora Dovat; Morgann Klink; Yali Ding
Journal:  Int J Mol Sci       Date:  2020-02-18       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.